We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Urinary Eosinophils Commonly Found After Bladder Surgery

By LabMedica International staff writers
Posted on 23 Nov 2011
Urine samples are examined for the presence of eosinophils, which are used to screen for acute interstitial nephritis (AIN). More...


Patients with urinary diversion surgeries such as ileal conduit surgery, frequently have an unusually high number of urinary eosinophils, a specific kind of white cell.

At the Mayo Clinic (Rochester, MN, USA) technologists examined urine samples from three cohorts with 20 patients in each group. In the first group, urinalysis samples were with a “stoma” source indicating a previous ileal conduit surgery; in the second group the urine samples had been clinically submitted for eosinophil quantification; and for the third cohort, randomly selected urinalysis samples was performed where there was with a minimum of 1-3 leucocytes per high-powered field. Urinary eosinophils were quantified after Hansel staining as the mean of independent counts by four technologists who did not know the source. Hansel stain is used to detect eosinophils in urine or other body fluids, the eosinophils staining red against a background of blue.

In the stoma group, eosinophils composed an average 19% of the urinary white cells even though none had a clinical suspicion of AIN. In contrast, only 3.5% and 4.6% of the urinary leucocytes were eosinophils among patients with clinically ordered eosinophiluria testing and in a random sample of patients with pyuria, respectively. Importantly, 18 out of 20 (90%) of the stoma patients had greater than 5% eosinophils, meeting the criterion for a positive test.

The authors concluded that patients with a previous ileal conduit surgery have markedly elevated urinary eosinophils, far in excess of typical patients with pyuria or those with clinically ordered eosinophiluria testing. Therefore, urinary eosinophils are not a useful screen for AIN in patients after ileal conduit surgery. Acute interstitial nephritis is an immunologic adverse reaction to certain drugs, often sulfonamide or methicillin. Acute renal failure, fever, rash, and proteinuria are characteristic of this condition. The study was published in the November 2011 edition of the journal Clinical Chemistry and Laboratory Medicine.

Related Links:

Mayo Clinic




Gold Member
Quality Control Material
iPLEX Pro Exome QC Panel
POC Helicobacter Pylori Test Kit
Hepy Urease Test
New
HPV Test
Allplex HPV28 Detection
New
Urine Analyzer
respons® UDS100
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Immunology

view channel
Image: Accurate immunotherapy selection for esophageal and GEJ carcinomas depends on consistent PD-L1 assessment (credit: Adobe Stock)

FDA Approval Expands Use of PD-L1 Companion Diagnostic in Esophageal and GEJ Carcinomas

Esophageal and gastroesophageal junction carcinomas (GEJ) have a poor prognosis, with approximately 16,250 deaths in the United States in 2025 and a five-year relative survival of 21.9%.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.